| Trial ID: | L7313 |
| Source ID: | NCT03983551
|
| Associated Drug: |
Dipeptidyl Peptidase 4 Inhibitor
|
| Title: |
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Proteinuria
|
| Interventions: |
DRUG: Dipeptidyl Peptidase 4 Inhibitor|DRUG: Sulfonylurea
|
| Outcome Measures: |
Primary: Change in urinary albumin-to-creatinine ratio, Change in urinary albumin-to-creatinine ratio after pharmacologic treatment, 24 weeks | Secondary: Change in serum glycated hemoglobin A1c, Change in serum glycated hemoglobin A1c after pharmacologic treatment, 24 weeks|Change in body weight, Change in body weight after pharmacologic treatment, 24 weeks|Change in serum creatinine, Change in serum creatinine after pharmacologic treatment, 24 weeks|Change in systolic blood pressure, Change in systolic blood pressure after pharmacologic treatment, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Changhua Christian Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
101
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-03-01
|
| Completion Date: |
2018-02-28
|
| Results First Posted: |
|
| Last Update Posted: |
2019-06-14
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03983551
|
